Innoviva, Inc. Share Price (NASDAQ: INVA)

Innoviva, Inc. Stock Performance

as on October 15, 2025 at 1:29 am IST

Day's Low
Day's High
$16.59
Day's Price Range
$16.85
$16.69
0.60%
Downside
0.96%
Upside
52 Week's Low
52 Week's High
$16.59
52-Week Price Range
$22
$16.69
0.60%
Downside
31.82%
Upside

Innoviva, Inc. share price movements today

Previous Close: $16.94
Open: $16.85
Volume: 603.6K
Day's Low - High: $16.59 - $16.85
52 Week Low - High: $16.59 - $22

Innoviva, Inc. Historical Returns

1 Month Return: -14.73 %
3 Month Return: -16.48 %
1 Year Return: -16.15 %
3 Year Return: + 26 %
5 Year Return: + 66.87 %

Innoviva, Inc. Stock Fundamentals & Key Indicators

Check Innoviva, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.1B

EPS (TTM)

1.43

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.63%

PE Ratio (TTM)

29.72

Industry PE ratio

-0.32286624203821657

PEG Ratio

0.2076

EBITDA

206.9M

Revenue (TTM)

370.2M

Profit Margin

10.44%

Return On Equity TTM

5.60%

Innoviva, Inc. Stock Valuation

Track how Innoviva, Inc. P/E has moved over time to understand its valuation trends.

Innoviva, Inc. in the last 5 years

Overview
Trends

Lowest (-19.64x)

March 31, 2025

Industry (-0.32x)

October 15, 2025

Today (29.72x)

October 15, 2025

Highest (67.91x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 29.72x

Innoviva, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Innoviva, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Innoviva, Inc.	SELL	$1.1B	66.87%	29.72	10.44%
Alnylam Pharmaceuticals, Inc.	BUY	$60.9B	226.08%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.1B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$104.4B	91.48%	28.99	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.1B	-2.15%	14.07	31.37%

Stock Returns calculator for Innoviva, Inc. Stock including INR - Dollar returns

The Innoviva, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Innoviva, Inc. investment value today

Current value as on today

₹89,722

Returns

₹10,278

(-10.28%)

Returns from Innoviva, Inc. Stock

₹16,046 (-16.05%)

Dollar Returns*

₹5,768 (+5.77%)

Analyst Recommendation on Innoviva, Inc. Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Innoviva, Inc.. Average target price of $36.2

Innoviva, Inc. Share Price Target

Get share price movements and forecasts by analysts on Innoviva, Inc..

What analysts predicted

53.9%UPSIDE

Target Price

$36.2

Current Price

$16.69

Analyzed by

6 Analysts

Target

$36.20

Innoviva, Inc. target price $36.2, a slight upside of 53.9% compared to current price of $16.69. According to 6 analysts rating.

Innoviva, Inc. Stock’s Investor Sentiment and Interest

Search interest for Innoviva, Inc. Stock has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 15, 2025 to October 15, 2025

Change:-29% versus previous 30 day period

Innoviva, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	76	80	67	89	80	103	89	91	88	100
Gross Profit	66	72	57	66	60	84	79	78	79	89
Operating Income	47	10	90	37	25	54	49	43	-41	-48
EBITDA	54	19	100	44	60	-23	19	35	-27	83
Interest Expense	4	4	4	5	5	5	5	4	4	4
Depreciation	3	8	9	-3	6	6	6	6	6	6
Income Before Tax	41	5	85	61	45	-39	6	24	-38	72
Income Tax Expense	6	4	3	0	8	-4	5	4	7	8
Net Income	34	1	82	61	36	-34	1	20	-46	63
Net Profit Margin	45.65%	1.58%	121.99%	68.93%	45.13%	-33.56%	1.36%	22.15%	-52.56%	63.51%

Innoviva, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	53	133	217	261	261	336	391	331	310	358
Gross Profit	51	132	217	261	261	0	391	317	261	322
Operating Income	31	108	183	238	246	321	375	209	176	166
EBITDA	46	125	191	236	231	317	361	322	248	99
Interest Expense	51	52	43	23	18	18	19	15	19	22
Depreciation	-	-	13	13	13	13	13	5	33	25
Income Before Tax	-18	59	134	210	232	354	445	286	194	37
Income Tax Expense	50	49	0	-196	41	60	76	66	14	13
Net Income	-18	59	134	395	157	224	265	213	179	23
Net Profit Margin	-34.77%	44.57%	61.76%	151.36%	60.26%	66.63%	67.84%	64.56%	57.89%	6.52%

Innoviva, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	1	82	61	36	-34	1	20	-46	63
Operating Cash Flow	38	43	33	37	43	48	59	48	44
Investing Cash Flow	-17	-25	-5	-43	-	-5	-15	-34	33
Financing Cash Flow	-9	-11	-14	-9	-5	0	0	0	1
Change in Cash	28	6	13	-15	38	43	44	14	78

Innoviva, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	59	134	406	190	293	368	220	179	23
Operating Cash Flow	60	141	223	257	313	363	201	141	188
Investing Cash Flow	-4	-23	3	-18	-314	43	-56	-66	-63
Financing Cash Flow	-97	-163	-237	-23	-29	-452	-55	-171	-13
Change in Cash	-41	-44	-10	215	-31	-44	89	-97	111

Global Institutional Holdings in Innoviva, Inc.

Funds	Holdings
BlackRock Inc	14.47%
Vanguard Group Inc	11.39%
Renaissance Technologies Corp	7.55%
Dimensional Fund Advisors, Inc.	6.81%
Franklin Resources Inc	4.49%

See all

Insights on Innoviva, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 88.63M → 100.28M (in $), with an average increase of 11.6% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -46.58M → 63.68M (in $), with an average increase of 173.1% per quarter
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 150.6% return, outperforming this stock by 122.6%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.8% return, outperforming this stock by 76.6%
NEGATIVE IMPACT
Price Dip
In the last 1 month, INVA stock has moved down by -13.4%

About Innoviva, Inc.

innoviva is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. innoviva's portfolio is anchored by the respiratory assets partnered with glaxo group limited (gsk), including relvar®/breo® ellipta® and anoro® ellipta®, which were jointly developed by innoviva and gsk. under the agreement with gsk, innoviva is eligible to receive associated royalty revenues from relvar®/breo® ellipta®, anoro® ellipta® and, if approved and commercialized, vi monotherapy, as well. in addition, innoviva retains a 15 percent economic interest in future payments made by gsk for earlier-stage programs partnered with theravance biopharma, inc. for more information, please visit innoviva's website at www.inva.com.

Organisation	Innoviva, Inc.
Headquarters	1350 Old Bayshore Highway, Burlingame, CA, United States, 94010
Industry	Health Technology
CEO	Mr. Pavel Raifeld C.F.A.
E-voting on shares	Click here to vote

Key Management of Innoviva, Inc.

Name	Title
Mr. Stephen Basso M.B.A.	Chief Financial Officer
Ms. Marianne Zhen CPA	Chief Accounting Officer & Secretary
Ms. Marcie Cain	Chief People Officer
Ms. Patricia M. Drake	Chief Commercial Officer-Innoviva Specialty Therapeutics, Inc.
Dr. David Altarac M.D., MPA	Chief Medical Officer of IST
Mr. Pavel Raifeld C.F.A.	CEO & Director

FAQs

What is Innoviva, Inc. share price today?

Innoviva, Inc. share price today is $16.69 as on October 15, 2025 at 1:29 am IST at the close of the market. Innoviva, Inc. share today touched a day high of $16.85 and a low of $16.59.

What is the 52 week high and 52 week low for Innoviva, Inc. share?

Innoviva, Inc. share touched a 52 week high of $22 on June 16, 2025 and a 52 week low of $16.59 on October 14, 2025. Innoviva, Inc. stock price today i.e. October 15, 2025 at 1:29 am IST is closed at $16.69,which is 24.14% down from its 52 week high and 0.60% up from its 52 week low.

What is Innoviva, Inc.'s market capitalisation today?

Innoviva, Inc. market capitalisation is $0.00T as on October 15, 2025 at 1:29 am IST.

How to invest in Innoviva, Inc. Stock (INVA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Innoviva, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Innoviva, Inc. Shares that will get you 0.0899 shares as per Innoviva, Inc. share price of $16.69 per share as on October 15, 2025 at 1:29 am IST.

What is the minimum amount required to buy Innoviva, Inc. Stock (INVA) from India?

Indian investors can start investing in Innoviva, Inc. (INVA) shares with as little as ₹88.771 or $1 (as of October 15, 2025 at 9:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹887.71 in Innoviva, Inc. stock (as per the Rupee-Dollar exchange rate as on October 15, 2025 at 9:37 am IST). Based on Innoviva, Inc. share’s latest price of $16.69 as on October 15, 2025 at 1:29 am IST, you will get 0.5992 shares of Innoviva, Inc.. Learn more about fractional shares .

What are the returns that Innoviva, Inc. has given to Indian investors in the last 5 years?

Innoviva, Inc. stock has given 66.87% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?